Dr. Sanjay Shrivastava is the founder and CEO of Innova Vascular. Sanjay has been involved in developing, commercializing, evaluating, and acquiring medical devices for over 20 years. During his career, Sanjay has held leadership positions at leading medical device companies including senior director, business development at Johnson & Johnson, vice president, upstream marketing and strategy at BTG, plc. (acquired by Boston Scientific Corporation), director global marketing at Medtronic, and director, research & development at Covidien/ev3 (merged with Medtronic). Sanjay cofounded BlackSwan Vascular–a clinical stage medical device startup company, where he serves on the board of directors. In 2020, BlackSwan Vascular, Inc. entered in a strategic alliance with Sirtex Medical. Additionally, Sanjay serves as a member of the board of directors at enVVeno Medical Corporation (Nasdaq: NVNO).